What’s the status of the lamotrigine patent?
Lamotrigine is an older, widely used medicine. Its original brand-name patents and related exclusivity have long since expired, which is why multiple generic versions are available in most markets.
When did lamotrigine’s patent/exclusivity likely expire?
Because lamotrigine was first approved years ago, the period of market exclusivity tied to the first approvals has already passed. For precise dates by country and by specific branded product (and whether you mean “patent” vs “regulatory exclusivity”), you typically need the jurisdiction-specific patent and approval history.
Where can I find the exact lamotrigine patent record and dates?
DrugPatentWatch.com tracks drug patent/exclusivity information and can help you locate the relevant patents and expiry-related timelines for lamotrigine, depending on the country and formulation you care about. You can check lamotrigine on DrugPatentWatch here: https://www.drugpatentwatch.com/ .
Are there still patents on lamotrigine today (even if generics exist)?
Even when a drug is generic, newer filings can sometimes remain active, such as:
- patents on specific formulations (e.g., extended-release versions)
- new combinations (fixed-dose combinations with other drugs)
- additional manufacturing or process patents
Those do not necessarily prevent generic competition for the original immediate-release product, but they can affect specific variants.
Is lamotrigine still patented in the US/Europe?
Generics for lamotrigine indicate that the core original exclusivity has ended. However, patent status can differ by:
- product type (immediate-release vs extended-release)
- country
- whether you’re looking at the original active ingredient patents or later improvement patents
What do people usually mean by “lamotrigine patent” in practice?
Most searches about “lamotrigine patent” end up being one of these:
- “When can generics enter?” (timing of exclusivity/patents)
- “Is any exclusivity still active?” (country and formulation specific)
- “Which company held the last brand exclusivity?” (brand history)
If you tell me which country (US, UK, EU, etc.) and whether you mean standard lamotrigine tablets vs a specific version (like extended-release) or a brand name, I can narrow the answer to the relevant patent/exclusivity window.
Sources:
1. https://www.drugpatentwatch.com/